VC
ARVN icon

VarCov Co’s Arvinas ARVN Stock Holding History

VarCov Co’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,591
Closed -$324K – 363
2026
Q1 		$324K Buy
+30,591
New +$379K 0.12% 267

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VarCov Co's ARVN Position: Q2 2026 in Review

VarCov Co sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 30,591 shares — an estimated $324K sold.

VarCov Co first reported a position in ARVN in Q1 2026 and held it in 1 quarter. The position peaked at $324K in Q1 2026. 198 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • VarCov Co reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
  • VarCov Co sold 30,591 Arvinas shares in Q2 2026, an estimated $324K.
  • VarCov Co first reported a position in Arvinas in Q1 2026 and held it in 1 quarter.
  • VarCov Co's Arvinas position peaked at $324K in Q1 2026.
  • 198 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.